Astrapi Corporation
Astrapi Corporation is a leader in revolutionary communication methods, specifically through spiral-based modulation. One capability is the Astrapi Spectrum Analyzer which enables an extremely precise method to measure continuously varying signal power which includes brain waves. This innovative technology is set to transform the next generation of communications by enhancing spectral efficiency and providing new ways to combat channel impairments. Astrapi's technology supports performance advances across various communications networks, including cellular, satellite, and defense communications, among others. Important medical applications of the Astrapi Spectrum Analyzer may include: 1. brain disorder diagnostics and measurement; 2. tumor localization; 3. enhanced prosthetics; and 4. brain-computer interfaces. Astrapi is in the process of spinning out a medical company to focus specifically on the medical applications of its Spectrum Analyzer. We welcome investors and collaborators. Our business model is to license to companies already in the medical field.
Astrapi Corporation
17217 Waterview Parkway, Suite 1.202, Dallas, TX 75252-8004
Astrapi Corporation is currently seeking investment
Astrapi Corporation is seeking a seed investment in the range of 1m-5m
What We Do
Astrapi provides consulting and engineering services to design communication systems tailored to specific needs using spiral-based signal modulation. They offer unique software tools for designing and testing these systems.
Astrapi has developed a simulation model in MATLAB and Simulink to support RF modem design and other system components, producing spiral-based waveform designs.
Astrapi offers engineering support to integrate spiral signals into communication system designs, leveraging their expertise in non-periodic waveforms.
Astrapi provides IP licenses for the use of its spiral modulation technology in R&D and commercial environments.
A transformative technology that increases spectral efficiency by transitioning from periodic to non-periodic signal modulation, allowing for enhanced communication capabilities.
A technique arising from spiral modulation that allows for a more spectrally-efficient representation of waveforms than traditional Fourier transforms.
Medical Spectrum Analyzer
Astrapi’s patented Spectrum Analyzer arose from our need in telecommunications to accurately and efficiently measure our occupied bandwidth (range of frequencies used by a signal). Traditional spectrum analyzers based on the Fourier transform contain an implicit assumption that the spectrum is at least approximately stationary (constant power in each frequency), an assumption which Spiral Modulation deliberately breaks. Astrapi’s Spectrum Analyzer avoids an assumption that the spectrum is stationary through a novel application of the superheterodyne principle from telecommunications. Since real-world spectra are almost never stationary, the Fourier stationary assumption is a problem for spectral analysis in many fields outside of telecommunications, which are now addressable by the Astrapi Spectrum Analyzer. The stationary limitation of the Fourier transform is well-known. This limitation has led to a vast literature of work-arounds to deal with this short-coming. These work-arounds include Fourier windows, wavelets, Welch’s Method and Bartlett’s Method. What they all have in common is that they are in the nature of attempting to fit a square peg into a round hole. The fundamental problem is intractable, and so one is left to choose among poor solutions.
Diagnostics
Application Area
Key People
CEO and Founder
Chief Intellectual Property and Corporate Counsel
Co-Founder/Chief Commercialization Officer
Senior R&D Scientist
Senior Engineer
Senior Vice President, Operations
News & Updates
Astrapi Corporation announced the issuance of three new patents, bringing their total to eighteen, covering solutions to improve spectral efficiency and secure signal transmissions.
Astrapi was awarded a contract for its 'Advanced SATCOM Using a Spiral Modulation-enabled SDR' capability, marking its second Phase II SBIR contract from the USAF.
The USAF Research Lab awarded Astrapi a contract to further develop its 'Symbol Waveform Hopping' signal protection capability.
Astrapi Corporation explores the generalization of Shannon's law for non-periodic channels, enhancing channel capacity and spectral efficiency.
Astrapi was honored as a 'Most Promising Start-up' at Euroconsult’s FinSpace 2017 for its innovative contributions to the telecommunications industry.
A patent for a unique capability to secure communications through advanced signal transmission techniques.